Regulation of CCN2 mRNA expression and promoter activity in activated hepatic stellate cells.
The matricellular protein connective tissue growth factor (CCN2) is considered a faithful marker of fibroblast activation in wound healing and in fibrosis. CCN2 is induced during activation of hepatic stellate cells (HSC). Here, we investigate the molecular basis of CCN2 gene expression in HSC. Fluoroscence activated cell sorting was used to investigate CCN2 expression in HSC in vivo in mice treated with CCl(4). CCN2 and TGF-beta mRNA expression were assessed by polymerase chain reaction as a function of culture-induced activation of HSC. CCN2 promoter/reporter constructs were used to map cis-acting elements required for basal and TGFbeta-induced CCN2 promoter activity. Real-time polymerase chain reaction analysis was used to further clarify signaling pathways required for CCN2 expression in HSC. CCl(4) administration in vivo increased CCN2 production by HSC. In vitro, expression of CCN2 and TGF-beta mRNA were concommitantly increased in mouse HSC between days 0 and 14 of culture. TGFbeta-induced CCN2 promoter activity required the Smad and Ets-1 elements in the CCN2 promoter and was reduced by TGFbeta type I receptor (ALK4/5/7) inhibition. CCN2 overexpression in activated HSC was ALK4/5/7-dependent. As CCN2 overexpression is a faithful marker of fibrogenesis, our data are consistent with the notion that signaling through TGFbeta type I receptors such as ALK5 contributes to the activation of HSC and hence ALK4/5/7 inhibition would be expected to be an appropriate treatment for liver fibrosis.
Leask
Andrew
A
CIHR Group in Skeletal Development and Remodeling, Division of Oral Biology and Department of Physiology and Pharmacology, Schulich School of Medicine and Dentistry, University of Western Ontario, Dental Sciences Building, London, Ontario, N6A 5C1, Canada, andrew.leask@schulich.uwo.ca.
Chen
Shaoqiong
S
Pala
Daphne
D
Brigstock
David R
DR
Ann Biol Clin (Paris). 1994;52(3):205-26
7998677
Pharmacol Ther. 1995 May;66(2):387-412
7667403
Reproduction. 2003 Feb;125(2):271-84
12578541
Mol Biol Cell. 2004 Dec;15(12):5635-46
15371538
Matrix Biol. 2002 Oct;21(6):473-82
12392758
Arthritis Rheum. 2006 Apr;54(4):1309-16
16575856
Endocr Rev. 1999 Apr;20(2):189-206
10204117
Hepatology. 1999 Oct;30(4):968-76
10498649
Methods. 2001 Dec;25(4):402-8
11846609
QJM. 2005 Jul;98(7):485-92
15955800
J Biol Chem. 2003 Oct 24;278(43):41728-33
12888575
Kidney Int. 2002 Oct;62(4):1149-59
12234285
J Biol Chem. 2003 Apr 11;278(15):13008-15
12571253
J Clin Invest. 1992 Jul;90(1):282-7
1634616
J Hepatol. 2004 Mar;40(3):431-8
15123357
J Cell Sci. 2006 Dec 1;119(Pt 23):4803-10
17130294
J Biol Chem. 2000 May 19;275(20):15220-5
10809757
Exp Cell Res. 2007 Mar 10;313(5):952-64
17239853
J Hepatol. 2000 May;32(5):754-61
10845662
EMBO J. 2007 Mar 7;26(5):1257-67
17318182
J Biol Chem. 2004 Mar 5;279(10):8848-55
14684735
J Biol Chem. 2001 Apr 6;276(14):10594-601
11152469
Arthritis Res Ther. 2006;8(2):R36
16469114
J Cell Commun Signal. 2007 Sep;1(2):85-90
18481199
Matrix Biol. 2007 Oct;26(8):625-32
17681742
J Biol Chem. 2008 Apr 4;283(14):9239-47
18276598
J Biol Chem. 2006 Apr 21;281(16):10715-26
16484225